IMV to Provide Updated Clinical Data at 2019 ASCO Annual Meeting on Lead Candidate DPX-Survivac in Ovarian Cancer and Other Solid Tumors

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology
corporation, today announced that two of its abstracts have been
accepted for presentation at the upcoming 2019
American Society of Clinical Oncology (ASCO) Annual Meeting, which
takes place May 31 a?? June 4 in Chicago, IL.

"Despite advances in other cancer treatment regimens, ovarian cancer
remains a particularly difficult-to-treat disease, and one that
represents one of the most underserved areas of the treatment
landscape,a?? saidA Frederic
Ors, Chief Executive Officer atA IMV. "Our presentations at ASCO
will allow us to update this important scientific audience on the
potential of DPX-Survivac monotherapy and on the progress we have made
since our groundbreaking ASCO
2018 presentation.a??

Presentation details are as follows:

Poster Title: "DPX-Survivac and intermittent low-dose
cyclophosphamide (CPA) with or without epacadostat (E) in the treatment
of subjects with advanced recurrent epithelial ovarian cancer (DeCidE1
trial): T cell responses and tumor infiltration correlate with tumor
Abstract Number: 5576
Session Title:
Gynecologic Cancer
Date and Time: June 1, 2019, 1:15 a?? 4:15
p.m. CT

Poster Title: "Early response assessment through multiparametric
MRI based endpoints in a phase II multicenter study evaluating the
efficacy of DPX-Survivac, intermittent low dose cyclophosphamide (CPA)
and pembrolizumab combination study in subjects with solid tumors.a??
: e14245
Session Title: online publication only
on May 15, 2019, 5:00 p.m. ET

ASCO will publish the official abstracts on its meeting website in
advance of the ASCO Annual Meeting at 5:00 p.m. ET on May 15. The
cut-off date for inclusion of data in the abstract was February 12,
2019. The final conference presentation will include additional data
collected between the abstract submission cutoff and the presentation
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »